Two Novel Deleterious Variants of Angiotensin‐I‐converting Enzyme Gene Identified in a Family with Recurrent Anhydramnios

Jingwei Wang,Qiao Bin,Biheng Cheng,Li Yan,Liang Xiong,Bi-Hua Tan,Mary McGrath,Gayle M. Smink,Chunhua Song,Yongqing Tong
DOI: https://doi.org/10.1002/mgg3.1239
2020-01-01
Molecular Genetics & Genomic Medicine
Abstract:AbstractBackgroundAnhydramnios results from the poor development of the placenta or problems with intrauterine development of the kidneys or urinary tract. Complete lack of amniotic fluid indicates a severe problem with the organs of the urinary system. The genes associated with anhydramnios show very diversity and are not yet well defined.MethodsWhole‐exome sequencing (WES) was used for an aborted male case around the 20th week of gestation diagnosed with anhydramnios. The resulted deleterious variants were verified by Sanger sequencing. Pathogenicity of deleterious variants was explored by in silico analysis.ResultsA maternally inherited deleterious frameshift variant, c.1454_1455insC, p.(S486Ffs29) in exon 9 and two paternally inherited missense variants c.1037C > G, p.(Ser346Trp) in exon 7 and c.1465A > G, p.(Asn489Asp) in exon 9 of Angiotensin‐I‐Converting Enzyme (ACE) gene were found and confirmed by Sanger sequencing. c.1454_1455insC, p.(S486Ffs29) and c.1037C > G, p.(Ser346Trp) were identified as two novel compound heterozygous deleterious variants. The pathogenicity of these deleterious variants was determined by in silico analysis and both the deleterious variants disrupt the structure of the ACE protein.ConclusionTwo novel compound heterozygous variants were identified in the case with anhydramnios, which may be associated with pathogenicity of anhydramnios. Our data also revealed that the WES approach may provide helpful information for genetic counseling of the families with anhydramnios.
What problem does this paper attempt to address?